Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Share News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
65.40    1.40 (2.19%)
Bid:
65.10
Ask:
65.90
Spread: 0.80 (1.229%)
Market Cap: £577.76m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Applied Graphene Materials To Float On AIM

Mon, 14th Oct 2013 09:55

LONDON (Alliance News) - Applied Graphene Minerals PLC Monday said it intends to raise funds by floating on AIM, with dealings expected to commence in November.

The company, which is a spin-out from Durham University, said listing on AIM would enable it to scale up production and accelerate commercialisation with blue chip partners.

"We have seen considerable interest from blue-chip businesses which have recognised the advantages of our production process, enabling us to continuously produce graphene cost efficiently on a commercial scale. Admission to AIM will provide the company with the funding for its next phase of development and build our position as a global graphene manufacturer," Jon Mabbitt, chief executive, said in a statement.

Graphene, the thinnest material known and yet one of the strongest, conducts electricity as efficiently as copper and outperforms other materials as a conductor of heat.

University of Manchester physicists Andre Geim and Kostya Novoselov won the 2010 Nobel Physics Prize for their work on graphene.

Applied Graphene Materials says that it can continuously produce high purity graphene at a cost efficient price, no mean feat considering the material's adoption has been hampered by the inability to produce graphene cost efficiently and at scale.

The company said it will be capable of producing one tonne of graphene per year at its first commercial scale facility based at the Wilton Science Park on Teesside, which was commissioned recently, though it wants to use the proceeds of the stock market floatation to increase capacity to eight tonnes per annum over the next 18 months.

Applied Graphene Materials expects graphene demand to increase to around 400 tonnes by 2017, up from current levels closer to 40 tonnes.

Its commercial strategy is based on becoming a supplier of graphene-based performance materials to partners manufacturing products incorporating graphene. The company already has commercial agreements in place with nine partners in different application areas.

Applied Graphene Materials is 25%-owned by intellectual property investor IP Group, which welcomed news of the IPO.

IP Group shares were Monday quoted at 138.59 pence, up 3.59 pence, or 2.7%.

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Copyright 2013 Alliance News Limited. All Rights Reserved.

Related News

WINNERS & LOSERS: Howden's acquisition; B&M signals recovery on track
3 Jun 2026

WINNERS & LOSERS: Howden's acquisition; B&M signals recovery on track

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday.

IP Group cheers trial results for Enterprise drug candidate
12 May 2026

IP Group cheers trial results for Enterprise drug candidate

(Alliance News) - IP Group PLC on Monday noted positive test results for a cystic fibrosis treatment developed by one of its portfolio firms.

IN BRIEF: IP Group names Michael Queen as next chair, succeeding Flint
7 May 2026

IN BRIEF: IP Group names Michael Queen as next chair, succeeding Flint

IP Group PLC - London-based investor in "breakthrough" science and technology firms - Appoints Michael Queen as chair designate, and as a non-executi...

Ip Group News

WINNERS & LOSERS: Howden's acquisition; B&M signals recovery on track
3 Jun 2026

WINNERS & LOSERS: Howden's acquisition; B&M signals recovery on track

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday.

IP Group cheers trial results for Enterprise drug candidate
12 May 2026

IP Group cheers trial results for Enterprise drug candidate

(Alliance News) - IP Group PLC on Monday noted positive test results for a cystic fibrosis treatment developed by one of its portfolio firms.

IN BRIEF: IP Group names Michael Queen as next chair, succeeding Flint
7 May 2026

IN BRIEF: IP Group names Michael Queen as next chair, succeeding Flint

IP Group PLC - London-based investor in "breakthrough" science and technology firms - Appoints Michael Queen as chair designate, and as a non-executi...

LONDON BROKER RATINGS: Jefferies cuts National Grid to 'hold'
18 Mar 2026

LONDON BROKER RATINGS: Jefferies cuts National Grid to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

IP Group asset value grows, remains confident in biotech potential
17 Mar 2026

IP Group asset value grows, remains confident in biotech potential

(Alliance News) - IP Group PLC on Tuesday highlighted a successful acquisition by portfolio holding Pfizer Inc, as the investor in science and technol...

LONDON MARKET OPEN: FTSE 100 outperforms Europe as oil rises
17 Mar 2026

LONDON MARKET OPEN: FTSE 100 outperforms Europe as oil rises

(Alliance News) - Stock prices in London opened mixed on Tuesday, as the FTSE 100 was helped by oil majors to outperform European peers, while Trustpi...

IP Group commits USD35 million to autonomous driving firm Oxa
4 Mar 2026

IP Group commits USD35 million to autonomous driving firm Oxa

(Alliance News) - Shares in IP Group PLC rose on Wednesday, as the firm noted its participation in a USD103 million fundraise by Oxa Autonomy Ltd.

Oxa secures $103m in Series D funding
4 Mar 2026

Oxa secures $103m in Series D funding

(Sharecast News) - Intellectual property investor IP Group revealed on Wednesday that portfolio company Oxa Autonomy has completed its Series D fundin...